Jones Financial Companies’s Ascendis Pharma A/S ASND Stock Holding History

Jones Financial Companies’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Buy	5,256 +1,510	+40%	+$353K	﹤0.01%	1735
2026 Q1	$813K	Buy	3,746 +3,518	+1,543%	+$789K	﹤0.01%	1810
2025 Q4	$48.6K	Hold	228	–	–	﹤0.01%	2539
2025 Q3	$43.8K	Buy	228 +83	+57%	+$15.5K	﹤0.01%	2438
2025 Q2	$25K	Sell	145 -204	-58%	-$33.2K	﹤0.01%	2499
2025 Q1	$54K	Buy	349 +102	+41%	+$14.6K	﹤0.01%	2027
2024 Q4	$34K	Buy	247 +197	+394%	+$25.9K	﹤0.01%	2039
2024 Q3	$7.23K	Hold	50	–	–	﹤0.01%	2332
2024 Q2	$6.82K	Buy	+50	New	+$6.8K	﹤0.01%	1874

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jones Financial Companies's ASND Position: Q2 2026 in Review

Jones Financial Companies increased its Ascendis Pharma A/S (ASND) stake by 40% in Q2 2026, buying an estimated $353K and bringing the position to 5,256 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

Jones Financial Companies first reported a position in ASND in Q2 2024 and has held it in 9 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Jones Financial Companies held 5,256 shares of Ascendis Pharma A/S worth $1.37M as of Q2 2026.
Jones Financial Companies bought 1,510 Ascendis Pharma A/S shares in Q2 2026, an estimated $353K.
Ascendis Pharma A/S made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1735 holding.
Jones Financial Companies first reported a position in Ascendis Pharma A/S in Q2 2024 and has held it in 9 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.